BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10542447)

  • 1. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future.
    Marnett LJ; Kalgutkar AS
    Trends Pharmacol Sci; 1999 Nov; 20(11):465-9. PubMed ID: 10542447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
    Cronstein BN
    Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.
    Marnett LJ; Kalgutkar AS
    Curr Opin Chem Biol; 1998 Aug; 2(4):482-90. PubMed ID: 9736921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for selective inhibition of COX-2 by nimesulide.
    Fabiola GF; Pattabhi V; Nagarajan K
    Bioorg Med Chem; 1998 Dec; 6(12):2337-44. PubMed ID: 9925294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX in a crystal ball: current status and future promise of prostaglandin research.
    FitzGerald GA; Loll P
    J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural approach for COX-2 inhibition.
    Michaux C; Charlier C
    Mini Rev Med Chem; 2004 Aug; 4(6):603-15. PubMed ID: 15279594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 selectivity and inflammatory processes.
    van Ryn J; Trummlitz G; Pairet M
    Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs.
    Smith WL; Meade EA; Dewitt DL
    Adv Exp Med Biol; 1997; 400A():189-96. PubMed ID: 9547557
    [No Abstract]   [Full Text] [Related]  

  • 12. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
    Garavito RM; DeWitt DL
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
    Kulkarni SK; Jain NK; Singh A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):291-8. PubMed ID: 11031730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of mammalian cyclooxygenases.
    Garavito RM; Mulichak AM
    Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2--10 years later.
    Hinz B; Brune K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):367-75. PubMed ID: 11805193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors in tumorigenesis (part I).
    Taketo MM
    J Natl Cancer Inst; 1998 Oct; 90(20):1529-36. PubMed ID: 9790545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors.
    Park CH; Siomboing X; Yous S; Gressier B; Luyckx M; Chavatte P
    Eur J Med Chem; 2002 Jun; 37(6):461-8. PubMed ID: 12204472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.